Morocco has taken a landmark step by officially exporting medical cannabis to Australia for the first time this week, signaling its growing ambition to become a key player in the international pharmaceutical market.
After years of legal and institutional groundwork, the North African country has successfully completed its inaugural shipment under the supervision of the National Agency for the Regulation of Cannabis Activities (ANRAC).
This regulatory body has been pivotal in managing the administrative and technical aspects of the export, collaborating closely with Australian health authorities and expert laboratories to ensure full compliance with stringent medical and trade standards.
The initial consignment consists of 50 kilograms of medical cannabis derived from a locally cultivated variety known as “Beldiya.” This marks an important milestone not only for Morocco’s agricultural sector but also for its pharmaceutical ambitions, as it positions itself within the rapidly expanding global medical cannabis industry.
“This export is a significant achievement reflecting Morocco’s commitment to rigorous regulatory frameworks and international cooperation,” commented a spokesperson from ANRAC.
“By meeting the exacting requirements of foreign markets such as Australia, Morocco is demonstrating its ability to produce high-quality medical cannabis products ready for global distribution.”
The move comes amid increasing global demand for medical cannabis, as more countries legalize its use and recognize its therapeutic potential. Morocco, already one of the world’s largest producers of cannabis resin, is now aiming to transition from traditional markets to fully regulated medical cannabis exports, attracting foreign investment and boosting its economy.
With this first official export, Morocco sets a precedent for future shipments and wider international partnerships, highlighting its strategic shift toward innovation and diversification in its agricultural and pharmaceutical industries.
About The Author
